Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oncotarget

Showing results (1101-1110 of 25,156) with videos related to

Pageof 2,516
Sort By:
Oncotarget|February 23, 2018
Effects of STC1 overexpression on tumorigenicity and metabolism of hepatocellular carcinomaCherry Ct Leung, Chris Kc Wong
Oncotarget|February 23, 2018
Spiclomazine displays a preferential anti-tumor activity in mutant <i>KRas</i>-driven pancreatic cancerXiaoyu Guo, Wenjing Zhao, Zuojia Liu, et al.
Oncotarget|February 23, 2018
<i>In vitro</i>, <i>in vivo</i> and <i>ex vivo</i> demonstration of the antitumoral role of hypocretin-1/orexin-A and almorexant in pancreatic ductal adenocarcinomaStéphanie Dayot, Daniela Speisky, Anne Couvelard, et al.
Oncotarget|February 23, 2018
Reverting iodine avidity of radioactive-iodine refractory thyroid cancer with a new tyrosine kinase inhibitor (K905-0266) excavated by high-throughput NIS (sodium iodide symporter) enhancer screening platform using dual reporter gene systemJi Min Oh, Senthilkumar Kalimuthu, Prakash Gangadaran, et al.
Oncotarget|February 23, 2018
Efficacy and safety of thrombopoietin receptor agonists in children with chronic immune thrombocytopenia: a meta-analysisJian-Chun Guo, Yi Zheng, Hai-Tao Chen, et al.
Oncotarget|December 20, 2018
IGFBP2 is a potential biomarker in acute kidney injury (AKI) and resveratrol-loaded nanoparticles prevent AKIHai-Lun Li, Zhuan Yan, Zun-Ping Ke, et al.
Oncotarget|December 20, 2018
Significance of intranuclear angiotensin-II type 2 receptor in oral squamous cell carcinomaSayako Matsushima-Otsuka, Rina Fujiwara-Tani, Takamitsu Sasaki, et al.
Oncotarget|December 20, 2018
Co-treatment of tumor cells with hyaluronan plus doxorubicin affects endothelial cell behavior independently of VEGF expressionDaiana L Vitale, Fiorella M Spinelli, Daiana Del Dago, et al.
Oncotarget|December 20, 2018
Clofarabine/busulfan-based reduced intensity conditioning regimens provides very good survivals in acute myeloid leukemia patients in complete remission at transplant: a retrospective study on behalf of the SFGM-TCAmandine Le Bourgeois, Myriam Labopin, Mathieu Leclerc, et al.
Oncotarget|December 15, 2018
Frequent activating STAT3 mutations and novel recurrent genomic abnormalities detected in breast implant-associated anaplastic large cell lymphomaPiers Blombery, Ella Thompson, Georgina L Ryland, et al.
Pageof 2,516

Showing results (1101-1110 of 25,156) with videos related to

Sort By:
Pageof 2,516
Oncotarget|February 23, 2018
Effects of STC1 overexpression on tumorigenicity and metabolism of hepatocellular carcinomaCherry Ct Leung, Chris Kc Wong
Oncotarget|February 23, 2018
Spiclomazine displays a preferential anti-tumor activity in mutant <i>KRas</i>-driven pancreatic cancerXiaoyu Guo, Wenjing Zhao, Zuojia Liu, et al.
Oncotarget|February 23, 2018
<i>In vitro</i>, <i>in vivo</i> and <i>ex vivo</i> demonstration of the antitumoral role of hypocretin-1/orexin-A and almorexant in pancreatic ductal adenocarcinomaStéphanie Dayot, Daniela Speisky, Anne Couvelard, et al.
Oncotarget|February 23, 2018
Reverting iodine avidity of radioactive-iodine refractory thyroid cancer with a new tyrosine kinase inhibitor (K905-0266) excavated by high-throughput NIS (sodium iodide symporter) enhancer screening platform using dual reporter gene systemJi Min Oh, Senthilkumar Kalimuthu, Prakash Gangadaran, et al.
Oncotarget|February 23, 2018
Efficacy and safety of thrombopoietin receptor agonists in children with chronic immune thrombocytopenia: a meta-analysisJian-Chun Guo, Yi Zheng, Hai-Tao Chen, et al.
Oncotarget|December 20, 2018
IGFBP2 is a potential biomarker in acute kidney injury (AKI) and resveratrol-loaded nanoparticles prevent AKIHai-Lun Li, Zhuan Yan, Zun-Ping Ke, et al.
Oncotarget|December 20, 2018
Significance of intranuclear angiotensin-II type 2 receptor in oral squamous cell carcinomaSayako Matsushima-Otsuka, Rina Fujiwara-Tani, Takamitsu Sasaki, et al.
Oncotarget|December 20, 2018
Co-treatment of tumor cells with hyaluronan plus doxorubicin affects endothelial cell behavior independently of VEGF expressionDaiana L Vitale, Fiorella M Spinelli, Daiana Del Dago, et al.
Oncotarget|December 20, 2018
Clofarabine/busulfan-based reduced intensity conditioning regimens provides very good survivals in acute myeloid leukemia patients in complete remission at transplant: a retrospective study on behalf of the SFGM-TCAmandine Le Bourgeois, Myriam Labopin, Mathieu Leclerc, et al.
Oncotarget|December 15, 2018
Frequent activating STAT3 mutations and novel recurrent genomic abnormalities detected in breast implant-associated anaplastic large cell lymphomaPiers Blombery, Ella Thompson, Georgina L Ryland, et al.
Pageof 2,516